2nd EJP RD Joint Transnational Call for Rare Diseases Research Project (JTC 2020)

Basic Information

The ERA-Net E-Rare has successfully implemented ten Joint Transnational Calls for rare disease research projects since 2006. This effort continues in the framework of the European Joint Programme on Rare Diseases (EJP RD) that has been established to further help in coordinating the research efforts of European, Associated and non-European countries in the field of rare diseases and implement the objectives of the International Rare Disease Research Consortium (IRDiRC).

Network EJP RD
Website https://www.ejprarediseases.org/index.php/open-call-jtc2020/
Aim of the joint call The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear future benefit for patients.
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Events
Launch date 18/12/2019
Deadline Pre-Proposal 18/02/2020 Submitted proposal: 173
Deadline Full-Proposal 16/06/2020 Submitted proposal: 30
Evaluation End Date 30/11/2020 Successful proposal: 18 Proposals funded: 18
Is call co-funded? No
Call follow up funding n/a
Call reasons n/a
Research fields
  • Health
Type of research n/a
Target groups n/a
Participating networks n/a

Organisations Participating

Country Organisation
Austria Austrian Science Fund (FWF)
Belgium National Fund for Scientific Research (FNRS)
Belgium Research Foundation Flanders (FWO)
Canada Canadian Institutes of Health Research (CIHR)
Canada Quebec Research Fund - Health (FRQS)
Czech Republic Ministry of Education Youth and Sports (MEYS-MSMT)
Finland Academy of Finland (AKA)
France French Foundation for Rare Diseases (FFRD)
France National Institute of Health and Medical Research (INSERM)
France National Research Agency (ANR)
Germany Federal Ministry of Education and Research (BMBF)
Germany German Research Foundation (DFG)
Greece General Secretariat for Research and Technology (GSRT)
Hungary National Research, Development and Innovation Office (NKFIH)
Ireland Health Research Board (HRB)
Israel Ministry of Health (CSO-MOH)
Italy Lombardy Foundation for Biomedical Research (FRRB)
Italy Ministry of Education, University and Research (MIUR)
Italy Ministry of Health (MOH/MDS)
Italy Tuscany Region (TOS)
Lithuania Research Council of Lithuania (LSC/LMT/RCL)
Luxembourg National Fund for Research (FNR)
Netherlands The Netherlands Organisation for Health Research and Development (ZonMw)
Poland National Centre for Research and Development (NCBiR)
Portugal Foundation for Science and Technology (FCT)
Slovakia Slovak Academy of Science (SAS/SAV)
Spain Institute of Health Carlos III (ISCIII)
Sweden Swedish Research Council (VR/SRC)
Switzerland Swiss National Science Foundation (SNSF/SNF)
Türkiye The Scientific and Technological Research Council of Turkey (TUBITAK)

Funded Projects

Acronym Title Start End No. partners
AAK-INSIGHT Aniridia – Novel therapeutic tools to treat or prevent progr... 8
ARMED Antioxidant treatment as a novel therapeutic option for micr... 5
CHARLIE CHAnging Rare disorders of LysInE metabolism 11
CureMILS A reprogramming-based strategy for drug repositioning in pat... 17
DBAGenCure Lentiviral-mediated gene therapy for Diamond Blackfan Anemia... 10
EpiThe4FSHD Safety and efficacy of a possible epigenetic therapy for FSH... 9
FANEDIT Gene editing as a novel therapeutic strategy in Fanconi anemia 8
GET-READY Genetic therapy for EYS- and USH2A-associated retinal disease 13
MECPer-3D Personalized MECP2 gene therapy using CRISPR/Cas9 technology... 6
ProDGNE Novel therapeutic approaches to target GNE Myopathy 6
SCN1A-up! Therapeutic strategies for Dravet syndrome: upregulation of ... 11
SILENCELQTS SGK1 inhibition as a novel therapeutic approach in Long QT s... 5
TC NER Transcription stress Counteracted by Nutritional interventio... 7
TREAT-ARCA Designing a toolbox of paradigmatic treatments for a targete... 10
TREAT-SGS Development and preclinical testing in human cell models and... 10
TREATKCNQ Targeted treatment for KCNQ related encephalopathies: retiga... 6
TreatRP Translating cGMP analogues into a treatment for retinitis pi... 11
WilsonMed Multimolecular targeting of copper overload in Wilson disease 11